Sahm Adrangi is a thriving businessman and analyst who is the chief investment officer and founder of Kerrisdale capital management LLC. The Kerrisdale Company established in 2009, grew exponentially and expanded its business aspects under the leadership of Mr. Adrangi. As an investment analyst, Sahm Adrangi’s company core business is in the line of short selling and publishing research. What’s more, Mr. Adrangi through his company strives to share misunderstood and over-hyped shorts to save the business community from investing where they would potentially lose.
Sahm Adrangi is a graduate of Yale University where he holds a Bachelor of Arts in Economics. Before starting his business at Kerrisdale, Mr. Adrangi worked in various companies where he served as an investment analyst. He worked at Deutsche Bank and served in the division of the leveraged finance group. Also, Sahm Adrangi worked at Chanin Capital Partners in the department of bankruptcy restructuring group which again he was very resourceful in the credit sector. Further, he worked at Longacre fund management still as an investment analyst. Read This Article for more information.
About Kerrisdale Company’s Achievements
The Kerrisdale’s chief responsibility is to have thorough research and investigations in a quest to correct the broadly held misconceptions about companies. The company then shares its findings and information regarding the companies through its platforms on Twitter, its websites, and third-party investing-related sites. Equally important, Sahm Adrangi has widened his scope of business whereby Kerrisdale researches on a variety of industries and companies. Some of the sectors that the company has examined on include the telecommunication sector, the biotechnology sector, and mining sector among others.
Furthermore, Sahm Adrangi was first recognized in the short selling business after his exposure of fraudulent businesses in in 2010 and 2011 respectively. He exposed Chinese companies that included the China-Biotics, Lihua International, China Marine Food and many more. Again, under the biotechnology sector, the company unveiled that the Bavarian Nordic vaccine of cancer was a flop and wouldn’t work in which they were right. Additionally, under Mr. Sahm Adrangi’s leadership the company has made it big in the field of hedging and accomplished its goals in short selling hence saving the investment community from widely held misconceptions